179 related articles for article (PubMed ID: 25903410)
1. Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms.
Ben-Shmuel S; Rostoker R; Scheinman EJ; LeRoith D
Handb Exp Pharmacol; 2016; 233():355-72. PubMed ID: 25903410
[TBL] [Abstract][Full Text] [Related]
2. All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.
Karmali R; Dalovisio A; Borgia JA; Venugopal P; Kim BW; Grant-Szymanski K; Hari P; Lazarus H
Blood Rev; 2015 Mar; 29(2):71-80. PubMed ID: 25433571
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology and molecular mechanisms linking obesity, diabetes, and cancer.
Ferguson RD; Gallagher EJ; Scheinman EJ; Damouni R; LeRoith D
Vitam Horm; 2013; 93():51-98. PubMed ID: 23810003
[TBL] [Abstract][Full Text] [Related]
4. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence.
LeRoith D; Novosyadlyy R; Gallagher EJ; Lann D; Vijayakumar A; Yakar S
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S4-6. PubMed ID: 18777452
[TBL] [Abstract][Full Text] [Related]
5. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
Vona-Davis L; Howard-McNatt M; Rose DP
Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
[TBL] [Abstract][Full Text] [Related]
6. Investigating new therapeutic strategies targeting hyperinsulinemia's mitogenic effects in a female mouse breast cancer model.
Rostoker R; Bitton-Worms K; Caspi A; Shen-Orr Z; LeRoith D
Endocrinology; 2013 May; 154(5):1701-10. PubMed ID: 23515289
[TBL] [Abstract][Full Text] [Related]
7. Obesity, type 2 diabetes and risk of digestive cancer.
Hillon P; Guiu B; Vincent J; Petit JM
Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
[TBL] [Abstract][Full Text] [Related]
8. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Gallagher EJ; LeRoith D
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
10. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome in obese Thai children and adolescents.
Iamopas O; Chongviriyaphan N; Suthutvoravut U
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
[TBL] [Abstract][Full Text] [Related]
12. Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms.
Pazaitou-Panayiotou K; Polyzos SA; Mantzoros CS
Obes Rev; 2013 Dec; 14(12):1006-22. PubMed ID: 24034423
[TBL] [Abstract][Full Text] [Related]
13. Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation.
Nunez NP; Oh WJ; Rozenberg J; Perella C; Anver M; Barrett JC; Perkins SN; Berrigan D; Moitra J; Varticovski L; Hursting SD; Vinson C
Cancer Res; 2006 May; 66(10):5469-76. PubMed ID: 16707476
[TBL] [Abstract][Full Text] [Related]
14. [The metabolic syndrome and type-2 diabetes mellitus as conditions predisposing for malignant tumors].
Halmos T; Suba I
Orv Hetil; 2008 Dec; 149(51):2403-11. PubMed ID: 19073451
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and cancer: epidemiology and potential mechanisms.
Joost HG
Diab Vasc Dis Res; 2014 Nov; 11(6):390-4. PubMed ID: 25268021
[TBL] [Abstract][Full Text] [Related]
16. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
[TBL] [Abstract][Full Text] [Related]
17. Role of adipokines in complications related to obesity: a review.
Gnacińska M; Małgorzewicz S; Stojek M; Łysiak-Szydłowska W; Sworczak K
Adv Med Sci; 2009; 54(2):150-7. PubMed ID: 19875356
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome: a novel high-risk state for colorectal cancer.
Ishino K; Mutoh M; Totsuka Y; Nakagama H
Cancer Lett; 2013 Jun; 334(1):56-61. PubMed ID: 23085010
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and cancer.
Zelenko Z; Gallagher EJ
Endocrinol Metab Clin North Am; 2014 Mar; 43(1):167-85. PubMed ID: 24582097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
